A detailed history of American Portfolios Advisors transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 70,307 shares of DNA stock, worth $708,694. This represents 0.01% of its overall portfolio holdings.

Number of Shares
70,307
Holding current value
$708,694
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$0.73 - $3.74 $51,324 - $262,948
70,307 New
70,307 $219 Million
Q2 2022

Mar 20, 2023

SELL
$2.2 - $4.2 $9,149 - $17,467
-4,159 Reduced 5.92%
66,148 $157 Million
Q1 2022

Mar 21, 2023

SELL
$2.83 - $8.69 $63,049 - $193,604
-22,279 Reduced 31.69%
48,028 $194 Million
Q4 2021

Mar 21, 2023

SELL
$8.31 - $14.92 $560,393 - $1.01 Million
-67,436 Reduced 95.92%
2,871 $23.9 Million
Q3 2021

Mar 22, 2023

SELL
$9.15 - $13.28 $625,009 - $907,116
-68,307 Reduced 97.16%
2,000 $23.2 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.